Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Apr 15;347(Pt 2):369–373. doi: 10.1042/0264-6021:3470369

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.

T Gómez del Pulgar 1, G Velasco 1, M Guzmán 1
PMCID: PMC1220968  PMID: 10749665

Abstract

Cannabinoids exert most of their effects in the central nervous system through the CB(1) cannabinoid receptor. This G-protein-coupled receptor has been shown to be functionally coupled to inhibition of adenylate cyclase, modulation of ion channels and activation of extracellular-signal-regulated kinase. Using Chinese hamster ovary cells stably transfected with the CB(1) receptor cDNA we show here that Delta(9)-tetrahydrocannabinol (THC), the major active component of marijuana, induces the activation of protein kinase B/Akt (PKB). This effect of THC was also exerted by the endogenous cannabinoid anandamide and the synthetic cannabinoids CP-55940 and HU-210, and was prevented by the selective CB(1) antagonist SR141716. Pertussis toxin and wortmannin blocked the CB(1) receptor-evoked activation of PKB, pointing to the sequential involvement of a G(i)/G(o) protein and phosphoinositide 3'-kinase. The functionality of the cannabinoid-induced stimulation of PKB was proved by the increased phosphorylation of glycogen synthase kinase-3 serine 21 observed in cannabinoid-treated cells and its prevention by SR141716 and wortmannin. Cannabinoids activated PKB in the human astrocytoma cell line U373 MG, which expresses the CB(1) receptor, but not in the human promyelocytic cell line HL-60, which expresses the CB(2) receptor. Data indicate that activation of PKB may be responsible for some of the effects of cannabinoids in cells expressing the CB(1) receptor.

Full Text

The Full Text of this article is available as a PDF (118.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B. A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996 Dec 2;15(23):6541–6551. [PMC free article] [PubMed] [Google Scholar]
  2. Bayewitch M., Rhee M. H., Avidor-Reiss T., Breuer A., Mechoulam R., Vogel Z. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J Biol Chem. 1996 Apr 26;271(17):9902–9905. doi: 10.1074/jbc.271.17.9902. [DOI] [PubMed] [Google Scholar]
  3. Bouaboula M., Bourrié B., Rinaldi-Carmona M., Shire D., Le Fur G., Casellas P. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem. 1995 Jun 9;270(23):13973–13980. doi: 10.1074/jbc.270.23.13973. [DOI] [PubMed] [Google Scholar]
  4. Bouaboula M., Perrachon S., Milligan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Pecceu F., Lupker J. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem. 1997 Aug 29;272(35):22330–22339. doi: 10.1074/jbc.272.35.22330. [DOI] [PubMed] [Google Scholar]
  5. Bouaboula M., Poinot-Chazel C., Bourrié B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., Casellas P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J. 1995 Dec 1;312(Pt 2):637–641. doi: 10.1042/bj3120637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bouaboula M., Poinot-Chazel C., Marchand J., Canat X., Bourrié B., Rinaldi-Carmona M., Calandra B., Le Fur G., Casellas P. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem. 1996 May 1;237(3):704–711. doi: 10.1111/j.1432-1033.1996.0704p.x. [DOI] [PubMed] [Google Scholar]
  7. Breivogel C. S., Sim L. J., Childers S. R. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther. 1997 Sep;282(3):1632–1642. [PubMed] [Google Scholar]
  8. Chan G. C., Hinds T. R., Impey S., Storm D. R. Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J Neurosci. 1998 Jul 15;18(14):5322–5332. doi: 10.1523/JNEUROSCI.18-14-05322.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coffer P. J., Jin J., Woodgett J. R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J. 1998 Oct 1;335(Pt 1):1–13. doi: 10.1042/bj3350001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cohen P., Alessi D. R., Cross D. A. PDK1, one of the missing links in insulin signal transduction? FEBS Lett. 1997 Jun 23;410(1):3–10. doi: 10.1016/s0014-5793(97)00490-0. [DOI] [PubMed] [Google Scholar]
  11. De Petrocellis L., Melck D., Palmisano A., Bisogno T., Laezza C., Bifulco M., Di Marzo V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8375–8380. doi: 10.1073/pnas.95.14.8375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Derocq J. M., Bouaboula M., Marchand J., Rinaldi-Carmona M., Ségui M., Casellas P. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett. 1998 Apr 3;425(3):419–425. doi: 10.1016/s0014-5793(98)00275-0. [DOI] [PubMed] [Google Scholar]
  13. Derocq J. M., Ségui M., Marchand J., Le Fur G., Casellas P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 1995 Aug 7;369(2-3):177–182. doi: 10.1016/0014-5793(95)00746-v. [DOI] [PubMed] [Google Scholar]
  14. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992 Dec 18;258(5090):1946–1949. doi: 10.1126/science.1470919. [DOI] [PubMed] [Google Scholar]
  15. Di Marzo V., Melck D., Bisogno T., De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 1998 Dec;21(12):521–528. doi: 10.1016/s0166-2236(98)01283-1. [DOI] [PubMed] [Google Scholar]
  16. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol. 1998 Apr;10(2):262–267. doi: 10.1016/s0955-0674(98)80149-x. [DOI] [PubMed] [Google Scholar]
  17. Fernández-Ruiz J. J., Berrendero F., Hernández M. L., Romero J., Ramos J. A. Role of endocannabinoids in brain development. Life Sci. 1999;65(6-7):725–736. doi: 10.1016/s0024-3205(99)00295-7. [DOI] [PubMed] [Google Scholar]
  18. Fruman D. A., Meyers R. E., Cantley L. C. Phosphoinositide kinases. Annu Rev Biochem. 1998;67:481–507. doi: 10.1146/annurev.biochem.67.1.481. [DOI] [PubMed] [Google Scholar]
  19. Khwaja A. Akt is more than just a Bad kinase. Nature. 1999 Sep 2;401(6748):33–34. doi: 10.1038/43354. [DOI] [PubMed] [Google Scholar]
  20. Leevers S. J., Vanhaesebroeck B., Waterfield M. D. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol. 1999 Apr;11(2):219–225. doi: 10.1016/s0955-0674(99)80029-5. [DOI] [PubMed] [Google Scholar]
  21. Martin B. R., Mechoulam R., Razdan R. K. Discovery and characterization of endogenous cannabinoids. Life Sci. 1999;65(6-7):573–595. doi: 10.1016/s0024-3205(99)00281-7. [DOI] [PubMed] [Google Scholar]
  22. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990 Aug 9;346(6284):561–564. doi: 10.1038/346561a0. [DOI] [PubMed] [Google Scholar]
  23. Munro S., Thomas K. L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993 Sep 2;365(6441):61–65. doi: 10.1038/365061a0. [DOI] [PubMed] [Google Scholar]
  24. Pertwee R. G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther. 1997;74(2):129–180. doi: 10.1016/s0163-7258(97)82001-3. [DOI] [PubMed] [Google Scholar]
  25. Rinaldi-Carmona M., Le Duigou A., Oustric D., Barth F., Bouaboula M., Carayon P., Casellas P., Le Fur G. Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system. J Pharmacol Exp Ther. 1998 Dec;287(3):1038–1047. [PubMed] [Google Scholar]
  26. Schwarz H., Blanco F. J., Lotz M. Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol. 1994 Nov;55(1):107–115. doi: 10.1016/0165-5728(94)90152-x. [DOI] [PubMed] [Google Scholar]
  27. Shepherd P. R., Withers D. J., Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J. 1998 Aug 1;333(Pt 3):471–490. doi: 10.1042/bj3330471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stefano G. B., Liu Y., Goligorsky M. S. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem. 1996 Aug 9;271(32):19238–19242. doi: 10.1074/jbc.271.32.19238. [DOI] [PubMed] [Google Scholar]
  29. Sánchez C., Galve-Roperh I., Canova C., Brachet P., Guzmán M. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 1998 Sep 25;436(1):6–10. doi: 10.1016/s0014-5793(98)01085-0. [DOI] [PubMed] [Google Scholar]
  30. Sánchez C., Galve-Roperh I., Rueda D., Guzmán M. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol. 1998 Nov;54(5):834–843. doi: 10.1124/mol.54.5.834. [DOI] [PubMed] [Google Scholar]
  31. Sánchez C., Velasco G., Guzmán M. Delta9-tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells. Brain Res. 1997 Aug 29;767(1):64–71. doi: 10.1016/s0006-8993(97)00631-8. [DOI] [PubMed] [Google Scholar]
  32. Valk P., Verbakel S., Vankan Y., Hol S., Mancham S., Ploemacher R., Mayen A., Löwenberg B., Delwel R. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood. 1997 Aug 15;90(4):1448–1457. [PubMed] [Google Scholar]
  33. Voth E. A., Schwartz R. H. Medicinal applications of delta-9-tetrahydrocannabinol and marijuana. Ann Intern Med. 1997 May 15;126(10):791–798. doi: 10.7326/0003-4819-126-10-199705150-00008. [DOI] [PubMed] [Google Scholar]
  34. Waksman Y., Olson J. M., Carlisle S. J., Cabral G. A. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther. 1999 Mar;288(3):1357–1366. [PubMed] [Google Scholar]
  35. Zhu W., Friedman H., Klein T. W. Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp Ther. 1998 Aug;286(2):1103–1109. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES